SMALL CAP MOVERS: Shares in drug developers Sareum and Valirx soar but oilers endure another bad week



So Brexit sent the world’s major stock markets into a bit of tiz and has floored the pound. But for the AIM market it is as if the June 23 ‘leave’ vote never happened.
In the last three months the AIM All Share has risen a creditable 15 per cent, outperforming the FTSE 100 (up 9.5 per cent).
And while some of the big IPOs, such as the re-privatisations Lloyds Banking Group have been put on hold, the junior bourse welcomed 10 new companies since late June. Not bad at all.
At the same time investors were more than willing to back the UK’s growth companies with existing AIM-listees raising... read more

 
30 September 2016 in Business, Views: 39
Source: Daily Mail
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31